Package 31722-556-12

{"route": ["ORAL"], "spl_id": "c3de2763-2221-d566-e053-2995a90ab15f", "openfda": {"nui": ["N0000000246", "N0000191001", "N0000175889", "N0000190114", "N0000182137", "N0000185607", "N0000190118", "N0000185503", "N0000190113", "N0000182141", "N0000191266", "N0000185507", "N0000187064", "N0000190117", "N0000190107"], "upc": ["0331722603607", "0331722556125"], "unii": ["O3J8G9O825", "2494G1JF75"], "rxcui": ["597730", "746645"], "spl_set_id": ["4e5005b8-f00c-4671-be09-bb927190760f"], "pharm_class_epc": ["Cytochrome P450 3A Inhibitor [EPC]", "Protease Inhibitor [EPC]"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "UDP Glucuronosyltransferases Inducers [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET, FILM COATED in 1 BOTTLE (31722-556-12)", "package_ndc": "31722-556-12", "marketing_start_date": "20210607"}, {"sample": false, "description": "8 BLISTER PACK in 1 CARTON (31722-556-31)  / 10 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "31722-556-31", "marketing_start_date": "20210607"}, {"sample": false, "description": "8 BLISTER PACK in 1 CARTON (31722-556-32)  / 10 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "31722-556-32", "marketing_start_date": "20210607"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (31722-556-60)", "package_ndc": "31722-556-60", "marketing_start_date": "20210607"}], "brand_name": "Lopinavir and ritonavir", "product_id": "31722-556_c3de2763-2221-d566-e053-2995a90ab15f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 3A Inhibitor [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Protease Inhibitor [EPC]", "Protease Inhibitor [EPC]", "UDP Glucuronosyltransferases Inducers [MoA]"], "product_ndc": "31722-556", "generic_name": "Lopinavir and ritonavir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lopinavir and ritonavir", "active_ingredients": [{"name": "LOPINAVIR", "strength": "200 mg/1"}, {"name": "RITONAVIR", "strength": "50 mg/1"}], "application_number": "ANDA091677", "marketing_category": "ANDA", "marketing_start_date": "20210607", "listing_expiration_date": "20261231"}